MARA
Marathon Digital Holdings, Inc.
There isn't enough reported data to score MARA yet.
OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
MARA Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| N/A | |
| N/A |
MARA's revenue and profitability are currently weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like MARA.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
MARA PE Valuation
MARA has no meaningful PE right now: it lost money over the past year.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
MARA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| -- | |
| Limited | |
| Low |
Analysts expect MARA's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
MARA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$7.88 | -465% |
| Q2 2026 | -$8.89 | -705% |
| Q1 2026 | -$5.45 | -$4.36 |
| Q4 2025 | -$3.69 | -315% |
| Q3 2025 | $2.16 | +148% |
| Q2 2025 | $1.47 | -10% |
| Q1 2025 | -$1.09 | -149% |
| Q4 2024 | $1.72 | +87% |
MARA has swung to a loss: it lost $7.88 per share over the past year, after a profit the year before.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over MARA on earnings quality, reporting a profit while its opponent remains loss making.
MARA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $164.2M | -35% |
| Q2 2026 | $174.9M | -27% |
| Q1 2026 | $174.6M | -18% |
| Q4 2025 | $202.3M | -5.6% |
| Q3 2025 | $252.4M | +92% |
| Q2 2025 | $238.5M | +64% |
| Q1 2025 | $213.9M | +29% |
| Q4 2024 | $214.4M | +37% |
MARA's revenue has slid since its 2025 peak: $164M last quarter, down 35% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 108% | +89 points |
| Q2 2026 | -298% | -583 points |
| Q1 2026 | -608% | -355 points |
| Q4 2025 | -697% | -856 points |
| Q3 2025 | 19% | +150 points |
| Q2 2025 | 285% | +445 points |
| Q1 2025 | -253% | -477 points |
| Q4 2024 | 159% | +41 points |
MARA has the edge over OSCR on profitability, with a higher operating margin.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over MARA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
MARA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$263.6M | +$20.3M |
| Q2 2026 | -$238.5M | +$43.8M |
| Q1 2026 | -$327M | -$72.7M |
| Q4 2025 | -$389.2M | +$110.7M |
| Q3 2025 | -$283.9M | -$85.8M |
| Q2 2025 | -$282.4M | -$150M |
| Q1 2025 | -$254.3M | -$156.9M |
| Q4 2024 | -$499.9M | -$407M |
MARA's free cash flow was −$1.2B over the past year, against −$1.3B the year before. Free cash flow isn't a meaningful measure for financial services companies like MARA.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over MARA on cash generation, producing positive trailing cash flow while its opponent burns cash.
MARA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +30% | +115M shares |
| 1 year | +13% | +55.5M shares |
| 3 years | +212% | +337M shares |
| 5 years | +416% | +400M shares |
MARA has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $13.7M |
| Q2 2026 | $7.7M |
| Q1 2026 | $7.5M |
| Q4 2025 | $3.7M |
| Q3 2025 | $7.7M |
| Q2 2025 | $15.2M |
| Q1 2025 | $20.4M |
| Q4 2024 | $5.9M |
MARA spent $33M buying back its own shares over the past year, down 34% from the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
MARA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 2.5x | Moderate |
| Q4 2024 | 2.9x | Moderate |
| Q3 2024 | 0.9x | Very low |
| Q2 2024 | 0.1x | Very low |
| Q1 2024 | 0.0x | Very low |
| Q4 2023 | -0.1x | Net Cash |
| Q3 2023 | 2.6x | Moderate |
MARA's net debt is about 2.1 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like MARA.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
MARA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.4 | Neutral |
| Stochastic | 10.2 | Oversold |
MARA's weekly RSI is 38 (neutral) and its Stochastic is 10 (oversold).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
MARA PE vs Financial Services Sector
| Metric | MARA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
MARA has no meaningful PE right now: it lost money over the past year.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
MARA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.54 | 16% below |
| 20 week MA | $10.3 | 30% below |
| 50 week MA | $10.6 | 32% below |
| 100 week MA | $13.3 | 46% below |
| 200 week MA | $14.4 | 50% below |
MARA is in a downtrend: it's below all five of its weekly moving averages, and 50% below its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over MARA on trend strength, trading above more of its moving averages.
MARA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $0.90 | $10.9 | +1113% |
| 2021 | $10.9 | $38.1 | +249% |
| 2022 | $38.1 | $3.62 | -91% |
| 2023 | $3.62 | $23.5 | +549% |
| 2024 | $23.5 | $18.4 | -21% |
| 2025 | $18.4 | $9.59 | -48% |
| 2026 YTD | $9.59 | $7.20 | -25% |
MARA's yearly returns have swung widely, from +1113% in 2020 to −91% in 2022. It's down 25% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over MARA on returns for 2026, with the stronger performance.